Related Experiment Video

Updated: Jun 30, 2026

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes
08:19

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes

Published on: June 22, 2020

Telomere biology in heart failure

Liza S M Wong1, Rudolf A de Boer, Nilesh J Samani

  • 1Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.

European Journal of Heart Failure
|September 26, 2008
PubMed

Insights

Aging increases cardiovascular disease risk. Telomere shortening, a marker of biological aging, is linked to heart failure, highlighting its role in disease development.

Area of Science:

  • Cardiovascular Biology
  • Aging Research
  • Genetics

Background:

  • Cardiovascular disease (CVD) prevalence rises with age, posing significant health and economic challenges.
  • Both genetic and environmental factors contribute to CVD development and progression.
  • Telomere shortening is an emerging mechanism linking aging, environmental factors, and age-associated diseases.

Purpose of the Study:

  • To review the role of telomere biology in the pathophysiology of heart failure.
  • To explore telomeres as indicators of biological age and their connection to age-related diseases.

Main Methods:

  • Review of existing literature on telomere biology and heart failure.
  • Analysis of the relationship between telomere length and cardiovascular aging.
  • Discussion of telomere shortening as a factor in heart failure development.

Main Results:

  • Telomere length is significantly reduced in patients with heart failure.
  • Telomere shortening serves as a biological age indicator.
  • Telomere dynamics are influenced by genetic and environmental factors.

Conclusions:

  • Telomere biology plays a crucial role in the pathophysiology of heart failure.
  • Understanding telomere shortening may offer insights into preventing and treating age-associated cardiovascular diseases.
  • Telomere length is a potential biomarker for biological aging and heart failure risk.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...